Open-uri20160406-3-16gdoks_thumb

Michelle Pflumm

Independent Scientific Editor and Writer

Boston, MA

Michelle Pflumm

I bring science to life in multimedia and the written word.

Open-uri20190905-4-k96420_profile

Sanofi Sets Its Sights on RIPK1 in ALS

A new licensing deal sets the stage for clinical testing of the RIPK1 inhibitor DNL747 in ALS.
ALS Research Forum Link to Story
Open-uri20190819-4-1vggla_profile

Potential SOD1 ALS Gene Therapy Right on Target Scientists Say

No off-target effects of a SOD1-lowering gene therapy could be detected in a preclinical analysis.
ALS Research Forum Link to Story
Open-uri20190820-4-hwk9qs_profile

Identifying Environmental Risk Factors in ALS

To identify environmental risk factors, scientists may need to study inherited cases of ALS.
ALS Research Forum Link to Story
Open-uri20190820-4-1fpaek4_profile

A New Study Raises Questions About How Axons Degenerate in ALS

A new study stokes the debate about whether to target SARM1 in ALS.
ALS Research Forum Link to Story
Open-uri20190822-4-1go96rz_profile

A New Test for C9orf72 ALS?

A new approach may enable the rapid detection of C9orf72 repeat expansions in larger cohorts including GWAS.
ALS Research Forum Link to Story
Open-uri20190822-4-kr32ie_profile

Traffic Tie-up May Lead to ALS, Scientists Say

The discovery of a new ALS gene may provide insight into why neurons degenerate in the disease.
ALS Research Forum Link to Story
Open-uri20190820-4-t1th7h_profile

Missing Connections May Explain Cognitive Challenges in ALS

Cognitive challenges may occur in ALS due to the loss of key synapses in the brain.
ALS Research Forum Link to Story
Open-uri20191016-4-xd0auj_profile

Clinicians Work Up an Approach to Confirm ALS Diagnosis

An emerging diagnostic test may help confirm the diagnosis of ALS – reducing the delay.
ALS Research Forum Link to Story
Open-uri20190820-4-yhqeyi_profile

An Emerging Clinical Trial Endpoint Gathers Strength in ALS

An emerging endpoint may help test potential ALS drugs in the clinic more quickly in a smaller sample size.
ALS Research Forum Link to Story
Open-uri20190820-4-9vnrte_profile

Scientists Go for the Gut in ALS

A new study aims to determine whether key microbial changes in the gut may be associated with ALS.
ALS Research Forum Link to Story
Open-uri20191016-4-dvptyr_profile

Retrotransposons Jump into the Mix in ALS

Retrotransposons buried in the genome may become reactivated in ALS, contributing to neurotoxicity.
ALS Research Forum Link to Story
Open-uri20190820-4-10o2knl_profile

Early Inflammation May Play a Role in FTD

Inflammation may contribute to the onset of at least one form of FTD.
ALS Research Forum Link to Story

About

Michelle Pflumm

Michelle Pflumm is an independent scientific editor and writer currently focusing on the neurosciences. An experienced multimedia journalist, she has covered the latest in science and medicine for Nature Medicine, Nature Methods, the ALS Research Forum and ALS Today. A huge NPR fan, Michelle also produced two stories for WBUR’s World of Ideas. In 2010, she worked as a multimedia content developer at Children’s Hospital Boston and in 2008, as a scientific editor for Nature Methods. She holds a Ph.D. in Molecular and Cellular Biology from the University of California, Berkeley, a B.A. in Chemistry from Haverford College and a M.S. in Science and Medical Journalism from Boston University.